For COVID-19 vaccines, Webby stated a crucial step is establishing an identical surveillance and testing community to flag the mutations that matter. Right now, there’s large geographic variability in monitoring and testing mutated variations. For instance, Britain does extra testing of the altering viral genome than the U.S.